Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2002-2005

  Mushtaq, S ^a   Irfan, S ^b   Sarma, J B ^c   Doumith, M ^a   Pike, R ^a   Pitout, J ^d   Livermore, D M ^a   Woodford, N ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Carbapenemase; E. coli; MLST; NDM lactamase

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M; BETA LACTAMASE NDM; CARBAPENEMASE; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; PROTEIN ARMA; PROTEIN RMTC; RNA 16S; RNA METHYLTRANSFERASE; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; INDIA; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PAKISTAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC VARIATION; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PAKISTAN; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80051681522     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr226     Document Type: Article

References (13)

1. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
2. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
3. Mulvey MR, Grant JM, Plewes K et al. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 2011; 17: 103-6.
4. Samuelsen O, Thilesen CM, Heggelund L et al. Identification of NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother 2011; 66: 670-2.
5. Poirel L, Hombrouck-Alet C, Freneaux C et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010; 10: 832.
6. Poirel L, Lagrutta E, Taylor P et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010; 54: 4914-6.
7. Pfeifer Y, Witte W, Holfelder M et al. NDM-1-producing Escherichia coli in Germany. Antimicrob Agents Chemother 2011; 55: 1318-9.
8. Peirano G, Ahmed-Bentley J, Woodford N et al. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis 2011; 17: 242-4.
9. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48: 5-16.
10. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
11. Woodford N, Fagan J, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154-5.
12. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
13. Mora A, Blanco M, Lopez C et al. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 2011; 37: 16-21.